Scientists were among the first to use the Internet to publish and share information and to communicate with each other. The suppliers of lab instruments and consumables were among the first to identify their customer’s digital behavior and respond with email marketing to direct them to the earliest online catalogs and e-commerce systems. This evolution […]
Author Archive for: bkelly
This author has not written his bio yet.
But we are proud to say that bkelly contributed 72 entries already.
Entries by bkelly
We recently conducted an in-depth survey of more than 500 scientists currently using, or planning to adopt, the remarkable technology CRISPR/Cas9. Based on user-submitted budget data and our estimate of the incidence in which CRISPR/Cas 9 is currently used in labs, we estimate the market for CRISPR/Cas9 genome editing products is $200 million. And the […]
This week we’ll be releasing the results of our survey of over 600 Scientists currently using, or planning to adopt, CRISPR/Cas9 on their research. Since the advent of molecular biology technology in the 1970s, there has been steady progress in the ability to alter, or edit, gene sequences at the genomic level. The recent development […]
We’re just a few weeks away from publishing our report on the fast growing market for CRISPR/Cas9 products. In the meantime, we’ve also been engaging with scientists on the ethical questions surround this exciting technology. Before the recent announcement from China that CRISPR had been used to modify human embryos, a slight majority favored such […]
Few in our industry would disagree with MIT’s Technology Review characterization of CRISPR/Cas9 as “the biggest biotech discovery of the century.” And yesterday’s revelation that Chinese scientists have already edited the genomes of human embryos has touched off yet another ethical debate as well as warnings that the findings show the technology is simply not […]
When we first started in the market research business we viewed ourselves primarily as a publisher of market research. We developed our off-the-shelf reports largely from quantitative surveys of scientific customers rather than from secondary sources as others were doing. Twenty years ago we were using postal mail surveys (remember those?). When we moved our […]
Earlier this week we closed the voting for the 2014 Life Science Industry Awards – our big party to be held in conjunction with the Society for Neuroscience annual meeting. In just a little over a week we collected nearly 3,000 completed ballots from scientific customers across the world. The scientists who voted reflect the […]
What do we need sales reps for, anyway? We thought that was a pretty good question. So much so, that we surveyed almost 1,000 scientists worldwide…
Labs can learn about, compare and purchase many of their products without ever talking to a live body at a supplier company at all.
Even the most ordinary interaction with vendors carries with it an aura. Some analysts refer to this as a “branded customer experience.”
December 9, 2021 12:13 pm
March 30, 2021 11:47 am
October 27, 2020 2:01 pm
BioInformatics, part of the Science and Medicine Group, is the leading research and advisory firm serving the life science and diagnostic industries. Our expertise includes primary quantitative and qualitative research in addition to secondary research and published reports. We own a proprietary, international community of more than 55,000 scientists and biomedical researchers to provide insights that grow businesses and move markets. Our multi-disciplinary team is comprised of industry veterans, market research experts, and survey statisticians.